Developer docs
API playgroundTry for free, no card

Search company profiles

Pelago

Full company profile

uuid0002z6y

Namestring
Pelago
Legal namestring
Pelago
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Pelago is a virtual-first digital clinic providing specialty substance use care for tobacco, alcohol, opioid, cannabis, and stimulant use disorders among adults and adolescents. Founded in 2017 and headquartered in New York City, the company combines a mobile app, cognitive behavioral therapy (CBT) content library, at-home remote monitoring devices (breathalyzers, urinary test kits, carbon monoxide monitors), and medication-assisted treatment (MAT) through its PelagoRX pharmacy integration, layered with live clinical support from physicians, nurses, coaches, and counselors. The platform offers same-day nationwide access, 24/7 availability, and confidential care, and operates a Centers of Excellence network of vetted inpatient facilities (RCA, Banyan) for higher-acuity needs. Pelago has accumulated 15 peer-reviewed publications and an independent Aon analysis of three years of claims data showing $11,829 in annual medical cost savings per member and a 5:1 ROI.

The technology stack includes AI-powered ambient clinical documentation integrated with EHR systems via AWS Amazon Connect Health, an automated care-pathway engine, and a personalization layer that adapts CBT content and interventions to member progress. Compliance posture covers HITRUST CSF, SOC 3, and HIPAA-aligned controls, which support enterprise and health-plan procurement. The company does not sell directly to consumers; access is gated by employer or health-plan eligibility, and pricing is utilization-based, quote-based, and contracted on a PEPM/PMPM or value basis, typically multi-year.

Pelago distributes exclusively through B2B channels: direct enterprise sales to self-insured employers, health-plan and PBM partnerships (Express Scripts Digital Health formulary listing, regional Blue and non-Blue plans, benefits consultants), and specialty-care platform integrations (Lantern). Reported customers span healthcare (Beacon Health System, Vitality, Evry Health), energy/utilities (Southern Company), entertainment (Live Nation), and industrial conglomerates (Philips, GE Appliances). To date, Pelago has raised approximately $151.6 million across multiple venture rounds, the most recent being a $58 million Series C led by Atomico in March 2024. The company is venture-backed, privately held, and led by CEO and co-founder Yusuf Sherwani alongside COO Maroof Ahmed, co-founder Sarim Siddiqui, President Frank Jennings, CSO Dr. Suzette Glasner, and CFO Patrick Leonard.

Short descriptiontext

Pelago is a New York-based virtual-first clinic delivering specialty substance use care (alcohol, tobacco, opioids, cannabis, stimulants) to adults and adolescents via self-insured employers, health plans, and PBMs. It combines CBT content, remote monitoring, medication-assisted treatment, and live clinical support under a recurring PEPM/PMPM contract model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
substance use treatment, virtual addiction care, digital health clinic, medication-assisted treatment, behavioral telehealth
Industry4 codes
1Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care)
CodeHLALAFAKPrimaryYes
2Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused)
CodeHLALAIAMPrimaryNo
3Behavioral Health & Substance Use Remote Monitoring
CodeHLACAFADPrimaryNo
4Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored)
CodeHLALACAKPrimaryNo
NAICS code2 codes
  • Outpatient Mental Health and Substance Abuse Centers621420
  • Offices of Physicians, Mental Health Specialists621112
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Substance Use Treatment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Employer Benefits Subscription
TypeSubscription Recurring
Description

Pelago is offered as an employee benefit through self-insured employers. Pricing is utilization-based and aligned with value delivered, with quotes based on organization size. Employers pay per-employee-per-month or per-eligible-member fees for access to the substance use management program.

pelagohealth.com
2Health Plan/Insurer Contracts
TypeSubscription Recurring
Description

Pelago partners with national health plans, regional Blue plans, and PBMs to provide substance use treatment as a covered benefit. Revenue comes from negotiated per-member-per-month fees or value-based contracts with demonstrated ROI.

pelagohealth.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Utilization-based pricing for employers
ModelUsage-basedBilling cadenceMulti-year contract
Notes

Simply tell us a few details about your organization, and we'll help you understand pricing (as well as the amount of money you'll save). First step involves entering number of employees to receive pricing estimates.

pelagohealth.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1PelagoRX
Description

A members' hub for medication-assisted treatment (MAT), offering confidential prescriptions and a straightforward integration with pharmacy partners.

pelagohealth.com
Core offering1 text field

Pelago operates a virtual-first digital clinic that delivers specialty substance use care for tobacco, alcohol, opioid, cannabis, and stimulant use disorders. The platform combines digital tools (CBT modules, tracking, craving management), live clinical support (physicians, nurses, coaches, counselors), medication-assisted treatment via PelagoRX, and at-home remote monitoring devices (breathalyzers, urinary test kits, CO monitors). Services are offered to members as an employee benefit through self-insured employers or as a covered benefit through health plans and PBMs, with same-day nationwide access and 24/7 availability.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • 62% reduction in alcohol use within 30 days
+9 more records
Product overview1 text field

Pelago operates as a unified virtual clinic platform for specialty substance use care, offering distinct treatment programs for five substance categories (alcohol, tobacco, opioids, cannabis, and stimulants) as a single integrated product. The platform combines a digital-first experience with live clinical support, featuring core components including PelagoRX for medication-assisted treatment, Remote Monitoring via at-home devices, and Contingency Management for behavioral incentives. Separate tracks serve employers, health plans, adolescents, and individuals, while the Aon Cost Efficiency Measurement tool provides ROI validation. All programs share common infrastructure including CBT content libraries, dedicated care teams, and progress tracking, unified under one member experience.

Product and service7 records
1Pelago Virtual Substance Use Clinic
CategorySubstance use treatment platform
Description

A virtual-first specialty substance use clinic providing personalized, evidence-based treatment for tobacco, alcohol, opioid, cannabis, and stimulant use disorders, combining digital tools with live clinical support from physicians, nurses, coaches, and counselors. Sold to self-insured employers, health plans, and PBMs as a covered benefit for their members.

2Alcohol Use Program
CategorySubstance use treatment program
Description

Virtual clinic for alcohol use offering personalized support for binge drinking and alcohol use disorders, featuring CBT content, breathalyzer devices, dedicated counselors, and naltrexone prescriptions. Members reduce alcohol use by 62% within 30 days on the program.

3Tobacco Cessation Program
CategorySubstance use treatment program
Description

Purpose-built virtual tobacco cessation program for smoking, smokeless tobacco, and vaping, featuring CBT content, nicotine replacement therapy, and connected devices for carbon monoxide monitoring. 44% of members report no tobacco use within 12 months; 52% biochemically-verified quit rate at 28 days.

4Opioid Use Program
CategorySubstance use treatment program
Description

Virtual clinic for opioid use addressing fentanyl, prescription opioid, and heroin use, offering 1:1 psychological therapy, CBT content, at-home urine testing, and suboxone (buprenorphine/naloxone) delivery. 67% of members are opioid-free for at least three months after starting treatment.

5Cannabis Use Disorder Program
CategorySubstance use treatment program
Description

Virtual treatment program for cannabis use disorder featuring dedicated care teams, CBT, motivational interviewing, and personalized tracking to address problematic cannabis use. Addresses the fact that 40% of adult SUDs and 60% of adolescent SUDs are linked to cannabis.

6Stimulant Use Disorder Program
CategorySubstance use treatment program
Description

Virtual treatment for stimulant use disorder featuring personalized care models, CBT content, contingency management incentives, and integrated care team access for coaching, counseling, and prescribing. Addresses a population of 9 million people reporting stimulant use in the past year.

7Adolescent Substance Use Program
CategorySubstance use treatment program
Description

Specialized substance use management program for adolescents featuring science-based screening tools, strict clinical guidelines, tailored consent protocols, and family support components. Addresses the unique needs of teen members struggling with substance use.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-05
Description

Pelago is integrated with Amazon Connect Health, AWS's agentic AI solution for healthcare. Pelago reports measurable outcomes including over a million ambient documentation visits, 275% adoption increase, and hundreds of clinician hours reclaimed monthly through the AWS-powered solution.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-27
Description

Lantern, a Dallas-based specialty care platform, launched an exclusive partnership with Pelago enabling Lantern's employer and health plan clients to access Pelago's substance use disorder treatment services. The partnership addresses a market of 49 million U.S. adult workers battling substance use disorders, with Pelago offering care teams, medication-assisted treatment, and vetted inpatient facilities.

3RCA (Recovery Centers of America)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

RCA is one of the clinically vetted inpatient treatment facilities that Pelago coordinates with for members who need additional expert support. Care is transitioned back to Pelago after discharge from RCA facilities.

pelagohealth.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Banyan is one of the clinically vetted inpatient treatment facilities in Pelago's Centers of Excellence network. Members have access to high-quality, clinically vetted inpatient treatment with care coordination and transition back to Pelago after discharge.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Pelago is featured on the Express Scripts Digital Health formulary, which offers rigorously evaluated digital health solutions in combination with support from Express Scripts specialist pharmacists. This helps health plans navigate digital health solutions and delivers average plan savings of more than $120,000 per digital solution.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Hazelden Betty Ford is a leading nonprofit addiction treatment provider with residential, outpatient, and digital programs. Indirect comparator as a major SUD care brand that increasingly partners with virtual providers like Pelago and represents the traditional care standard Pelago aims to displace.

TypeBroad incumbent
Description

Spring Health is a comprehensive mental health benefits platform for employers offering therapy, coaching, medication management, and SUD support. Broader incumbent that bundles SUD into a wider mental health offering, competing for the same employer benefits wallet.

TypeDirect peer
Description

Lionrock Recovery delivers online counseling and group therapy for substance use disorders via telehealth. Direct peer in virtual SUD treatment delivery, particularly the teletherapy layer that complements Pelago's clinical offering.

4Ophelia
TypeDirect peer
Description

Ophelia is a virtual opioid use disorder treatment provider offering medication-assisted treatment via telehealth, with a focus on discreet, at-home Suboxone prescriptions. Direct competitor in teleprescribing-based OUD care.

TypeBroad incumbent
Description

Modern Health is a global mental health platform offering therapy, coaching, and digital self-serve tools to employers. Broader incumbent competing with Pelago for mental health/SUD benefits allocations across mid-market and enterprise.

TypeDirect peer
Description

Workit Health is a digital SUD treatment platform offering virtual medication-assisted treatment and therapy for opioid and alcohol use disorders, with employer and health plan distribution. Closest direct competitor to Pelago in the virtual SUD clinic category.

TypeDirect peer
Description

Boulder Care is a telemedicine provider focused specifically on opioid use disorder, offering buprenorphine-based MAT, counseling, and care navigation. Direct competitor to Pelago in teleprescribing for OUD with a similar value-based contracting model.

TypeBroad incumbent
Description

Talkspace is an online therapy platform serving employers, health plans, and individuals. Broader incumbent in the virtual behavioral health category, increasingly expanding into substance use support that overlaps with Pelago's offering.

TypeBroad incumbent
Description

Lyra Health is an enterprise mental health benefits platform providing therapy, coaching, and medication management to global employers. Broader incumbent whose expanding SUD services compete with Pelago for employer benefits budget.

TypeDirect peer
Description

Quit (formerly Quit Genius) is a digital tobacco and substance use cessation platform serving employers and health plans. Direct peer to Pelago in digital SUD/telehealth delivery for employer benefits with a similar ROI-led go-to-market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors22 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pelago

Substance Use Treatmentpelagohealth.com

Pelago is a New York-based virtual-first clinic delivering specialty substance use care (alcohol, tobacco, opioids, cannabis, stimulants) to adults and adolescents via self-insured employers, health plans, and PBMs. It combines CBT content, remote monitoring, medication-assisted treatment, and live clinical support under a recurring PEPM/PMPM contract model.

What Pelago does

Pelago is a virtual-first digital clinic providing specialty substance use care for tobacco, alcohol, opioid, cannabis, and stimulant use disorders among adults and adolescents. Founded in 2017 and headquartered in New York City, the company combines a mobile app, cognitive behavioral therapy (CBT) content library, at-home remote monitoring devices (breathalyzers, urinary test kits, carbon monoxide monitors), and medication-assisted treatment (MAT) through its PelagoRX pharmacy integration, layered with live clinical support from physicians, nurses, coaches, and counselors. The platform offers same-day nationwide access, 24/7 availability, and confidential care, and operates a Centers of Excellence network of vetted inpatient facilities (RCA, Banyan) for higher-acuity needs. Pelago has accumulated 15 peer-reviewed publications and an independent Aon analysis of three years of claims data showing $11,829 in annual medical cost savings per member and a 5:1 ROI.

The technology stack includes AI-powered ambient clinical documentation integrated with EHR systems via AWS Amazon Connect Health, an automated care-pathway engine, and a personalization layer that adapts CBT content and interventions to member progress. Compliance posture covers HITRUST CSF, SOC 3, and HIPAA-aligned controls, which support enterprise and health-plan procurement. The company does not sell directly to consumers; access is gated by employer or health-plan eligibility, and pricing is utilization-based, quote-based, and contracted on a PEPM/PMPM or value basis, typically multi-year.

Pelago distributes exclusively through B2B channels: direct enterprise sales to self-insured employers, health-plan and PBM partnerships (Express Scripts Digital Health formulary listing, regional Blue and non-Blue plans, benefits consultants), and specialty-care platform integrations (Lantern). Reported customers span healthcare (Beacon Health System, Vitality, Evry Health), energy/utilities (Southern Company), entertainment (Live Nation), and industrial conglomerates (Philips, GE Appliances). To date, Pelago has raised approximately $151.6 million across multiple venture rounds, the most recent being a $58 million Series C led by Atomico in March 2024. The company is venture-backed, privately held, and led by CEO and co-founder Yusuf Sherwani alongside COO Maroof Ahmed, co-founder Sarim Siddiqui, President Frank Jennings, CSO Dr. Suzette Glasner, and CFO Patrick Leonard.

Pelago firmographics

Firmographics
Name
Pelago
Legal name
Pelago
Website
https://pelagohealth.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
Pelago is a New York-based virtual-first clinic delivering specialty substance use care (alcohol, tobacco, opioids, cannabis, stimulants) to adults and adolescents via self-insured employers, health plans, and PBMs. It combines CBT content, remote monitoring, medication-assisted treatment, and live clinical support under a recurring PEPM/PMPM contract model.
Ownership category
akta.pro rank

Pelago industry classification

Industry
Product category
Substance Use Treatment
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Physicians, Mental Health Specialists (621112)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care) (HLALAFAK)
akta.pro secondary industries
Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused) (HLALAIAM), Behavioral Health & Substance Use Remote Monitoring (HLACAFAD), Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored) (HLALACAK)

Keywords

  • Substance use treatment
  • Virtual addiction care
  • Digital health clinic
  • Medication-assisted treatment
  • Behavioral telehealth

Where Pelago is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Pelago business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Employer Benefits Subscription: Pelago is offered as an employee benefit through self-insured employers. Pricing is utilization-based and aligned with value delivered, with quotes based on organization size. Employers pay per-employee-per-month or per-eligible-member fees for access to the substance use management program.
  2. Health Plan/Insurer Contracts: Pelago partners with national health plans, regional Blue plans, and PBMs to provide substance use treatment as a covered benefit. Revenue comes from negotiated per-member-per-month fees or value-based contracts with demonstrated ROI.

Pricing tiers

ModelBillingPrice
Usage-basedMulti-year contractUtilization-based pricing for employers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Pelago product offering

Product offering

Core offering

Pelago operates a virtual-first digital clinic that delivers specialty substance use care for tobacco, alcohol, opioid, cannabis, and stimulant use disorders. The platform combines digital tools (CBT modules, tracking, craving management), live clinical support (physicians, nurses, coaches, counselors), medication-assisted treatment via PelagoRX, and at-home remote monitoring devices (breathalyzers, urinary test kits, CO monitors). Services are offered to members as an employee benefit through self-insured employers or as a covered benefit through health plans and PBMs, with same-day nationwide access and 24/7 availability.

Product overview

Pelago operates as a unified virtual clinic platform for specialty substance use care, offering distinct treatment programs for five substance categories (alcohol, tobacco, opioids, cannabis, and stimulants) as a single integrated product. The platform combines a digital-first experience with live clinical support, featuring core components including PelagoRX for medication-assisted treatment, Remote Monitoring via at-home devices, and Contingency Management for behavioral incentives. Separate tracks serve employers, health plans, adolescents, and individuals, while the Aon Cost Efficiency Measurement tool provides ROI validation. All programs share common infrastructure including CBT content libraries, dedicated care teams, and progress tracking, unified under one member experience.

Differentiator

Problem solved

Functional benefit

Brands

  • PelagoRX: A members' hub for medication-assisted treatment (MAT), offering confidential prescriptions and a straightforward integration with pharmacy partners.

Products and services

  • Pelago Virtual Substance Use Clinic A virtual-first specialty substance use clinic providing personalized, evidence-based treatment for tobacco, alcohol, opioid, cannabis, and stimulant use disorders, combining digital tools with live clinical support from physicians, nurses, coaches, and counselors. Sold to self-insured employers, health plans, and PBMs as a covered benefit for their members.
  • Alcohol Use Program Virtual clinic for alcohol use offering personalized support for binge drinking and alcohol use disorders, featuring CBT content, breathalyzer devices, dedicated counselors, and naltrexone prescriptions. Members reduce alcohol use by 62% within 30 days on the program.
  • Tobacco Cessation Program Purpose-built virtual tobacco cessation program for smoking, smokeless tobacco, and vaping, featuring CBT content, nicotine replacement therapy, and connected devices for carbon monoxide monitoring. 44% of members report no tobacco use within 12 months; 52% biochemically-verified quit rate at 28 days.
  • Opioid Use Program Virtual clinic for opioid use addressing fentanyl, prescription opioid, and heroin use, offering 1:1 psychological therapy, CBT content, at-home urine testing, and suboxone (buprenorphine/naloxone) delivery. 67% of members are opioid-free for at least three months after starting treatment.
  • Cannabis Use Disorder Program Virtual treatment program for cannabis use disorder featuring dedicated care teams, CBT, motivational interviewing, and personalized tracking to address problematic cannabis use. Addresses the fact that 40% of adult SUDs and 60% of adolescent SUDs are linked to cannabis.
  • Stimulant Use Disorder Program Virtual treatment for stimulant use disorder featuring personalized care models, CBT content, contingency management incentives, and integrated care team access for coaching, counseling, and prescribing. Addresses a population of 9 million people reporting stimulant use in the past year.
  • Adolescent Substance Use Program Specialized substance use management program for adolescents featuring science-based screening tools, strict clinical guidelines, tailored consent protocols, and family support components. Addresses the unique needs of teen members struggling with substance use.

Quantifiable outcome

  • 62% reduction in alcohol use within 30 days
  • +9 more outcomes

Companies that use Pelago

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Pelago technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability5 records

Feature5 records

Pelago partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Amazon Web Services (AWS)coreTechnology or Integration · 5 March 2026Pelago is integrated with Amazon Connect Health, AWS's agentic AI solution for healthcare. Pelago reports measurable outcomes including over a million ambient documentation visits, 275% adoption increase, and hundreds of clinician hours reclaimed monthly through the AWS-powered solution.
  • LanterncoreStrategic or Co-development Partner · 27 January 2025Lantern, a Dallas-based specialty care platform, launched an exclusive partnership with Pelago enabling Lantern's employer and health plan clients to access Pelago's substance use disorder treatment services. The partnership addresses a market of 49 million U.S. adult workers battling substance use disorders, with Pelago offering care teams, medication-assisted treatment, and vetted inpatient facilities.
  • RCA (Recovery Centers of America)minorStrategic or Co-development PartnerRCA is one of the clinically vetted inpatient treatment facilities that Pelago coordinates with for members who need additional expert support. Care is transitioned back to Pelago after discharge from RCA facilities.
  • BanyanminorStrategic or Co-development PartnerBanyan is one of the clinically vetted inpatient treatment facilities in Pelago's Centers of Excellence network. Members have access to high-quality, clinically vetted inpatient treatment with care coordination and transition back to Pelago after discharge.
  • Express ScriptscoreChannel Partner/ Reseller/ DistributorPelago is featured on the Express Scripts Digital Health formulary, which offers rigorously evaluated digital health solutions in combination with support from Express Scripts specialist pharmacists. This helps health plans navigate digital health solutions and delivers average plan savings of more than $120,000 per digital solution.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Pelago competitors and assessment

Company assessment

Others

  • Hazelden Betty Ford Foundation: Hazelden Betty Ford is a leading nonprofit addiction treatment provider with residential, outpatient, and digital programs. Indirect comparator as a major SUD care brand that increasingly partners with virtual providers like Pelago and represents the traditional care standard Pelago aims to displace.

Broad incumbents

  • Spring Health: Spring Health is a comprehensive mental health benefits platform for employers offering therapy, coaching, medication management, and SUD support. Broader incumbent that bundles SUD into a wider mental health offering, competing for the same employer benefits wallet.
  • Modern Health: Modern Health is a global mental health platform offering therapy, coaching, and digital self-serve tools to employers. Broader incumbent competing with Pelago for mental health/SUD benefits allocations across mid-market and enterprise.
  • Talkspace: Talkspace is an online therapy platform serving employers, health plans, and individuals. Broader incumbent in the virtual behavioral health category, increasingly expanding into substance use support that overlaps with Pelago's offering.
  • Lyra Health: Lyra Health is an enterprise mental health benefits platform providing therapy, coaching, and medication management to global employers. Broader incumbent whose expanding SUD services compete with Pelago for employer benefits budget.

Direct peers

  • Lionrock Recovery: Lionrock Recovery delivers online counseling and group therapy for substance use disorders via telehealth. Direct peer in virtual SUD treatment delivery, particularly the teletherapy layer that complements Pelago's clinical offering.
  • Ophelia: Ophelia is a virtual opioid use disorder treatment provider offering medication-assisted treatment via telehealth, with a focus on discreet, at-home Suboxone prescriptions. Direct competitor in teleprescribing-based OUD care.
  • Workit Health: Workit Health is a digital SUD treatment platform offering virtual medication-assisted treatment and therapy for opioid and alcohol use disorders, with employer and health plan distribution. Closest direct competitor to Pelago in the virtual SUD clinic category.
  • Boulder Care: Boulder Care is a telemedicine provider focused specifically on opioid use disorder, offering buprenorphine-based MAT, counseling, and care navigation. Direct competitor to Pelago in teleprescribing for OUD with a similar value-based contracting model.
  • Quit Genius (Quit.com): Quit (formerly Quit Genius) is a digital tobacco and substance use cessation platform serving employers and health plans. Direct peer to Pelago in digital SUD/telehealth delivery for employer benefits with a similar ROI-led go-to-market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Pelago social profiles

Digital presence

Pelago compliance and trust

Trust signal

Compliance3 records

Pelago financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pelago leadership team

Management profile

Number of profiles

Profiles9 records

Pelago funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors22 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pelago M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pelago

What does Pelago do?

Pelago operates a virtual-first digital clinic that delivers specialty substance use care for tobacco, alcohol, opioid, cannabis, and stimulant use disorders. The platform combines digital tools (CBT modules, tracking, craving management), live clinical support (physicians, nurses, coaches, counselors), medication-assisted treatment via PelagoRX, and at-home remote monitoring devices (breathalyzers, urinary test kits, CO monitors). Services are offered to members as an employee benefit through self-insured employers or as a covered benefit through health plans and PBMs, with same-day nationwide access and 24/7 availability.

Is Pelago a public or private company?

Pelago is a private company. It is classified as venture growth investor backed and is currently operating.

When was Pelago founded?

Pelago was founded in 2017. It employs 101 to 250 people.

Where is Pelago based?

Pelago is headquartered in New York, United States, in the North America region.

How does Pelago make money?

Two revenue lines are on record. Employer Benefits Subscription is the primary driver. The others are health Plan/Insurer Contracts.

Who are Pelago's main competitors?

Hazelden Betty Ford Foundation is listed as an others. Broad incumbents are Spring Health, Modern Health, Talkspace and Lyra Health. Direct peers are Lionrock Recovery, Ophelia, Workit Health, Boulder Care and Quit Genius (Quit.com).

Does Pelago have an API?

No public API is recorded for Pelago.

What industry is Pelago in?

Pelago's product category is Substance Use Treatment. Its primary akta.pro industry code is HLALAFAK, Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care), with a secondary code of HLALAIAM, Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused). Its NAICS code is 621420 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FierceHealthcareAI-enabled Pelago expands from SUD care to mental health, behavioral addictionsPelago expanded into mental health and behavioral addiction care, offering a consolidated platform for co-occurring conditions. The company claims nearly $12,000 in annual savings per SUD patient and reports that Sona, its AI agent, improves outcomes for patients with depression or anxiety. Member access to the platform begins in November.MedCity NewsPelago Unveils New Behavioral Health Platform for Substance Use, Mental Health and Behavioral Addiction CarePelago launched its Behavioral Health Platform at a Nashville conference, unifying substance use, mental health, and behavioral addiction care under one contract. The platform uses its Sona AI tool for triage, with studies showing 20-25% fewer poor mental health days. Pelago aims to make mental health cost deflationary within two to three years.PR NewswirePelago Launches Behavioral Health Platform Uniting Substance Use, Mental Health and Behavioral Addiction CarePelago announced its Behavioral Health Platform, uniting substance use, mental health, and behavioral addiction care under one contract and member record. The platform uses Sona, a voice-first clinical AI, to assess members under licensed clinical supervision. Member access begins in November, ahead of January 1 plan years.Harvard GazetteMatthew Stewart, S.M. '20, Ph.D. '23: Building safer and more accountable AIMatthew Stewart, a former Harvard postdoctoral researcher, now serves as a lead AI researcher at Pelago Health, where he develops AI tools with safety guardrails for digital substance use care. His work focuses on integrating clinical oversight into AI interactions to monitor mental health crises and ensure algorithmic accountability, building on his previous research in environmental science and machine learning.BhbusinessExclusive: SUD Provider Pelago Pivots to Behavioral Health with New BotPelago, a virtual addiction treatment platform based in New York City, has launched an AI chatbot named Sona to expand its services into broader behavioral health care beyond substance use disorder. This strategic pivot aims to address healthcare affordability by providing AI-led support with clinical escalation capabilities for mental wellness.Bhbusiness5 SUD Companies to Watch in 2026Behavioral Health Business identifies five substance use disorder companies—Summit BHC, Addiction Recovery Care, Ethema Health, Recover Now, and Pelago—as key market players facing distinct challenges and opportunities in 2026. Summit BHC navigates financial distress and potential sale, while Addiction Recovery Care deals with CEO fraud charges and failed acquisition plans. Meanwhile, Ethema Health seeks new targets after its merger fell through, Recover Now expands via consolidation, and Pelago launches an AI tool to diversify into broader behavioral health.Amazon Web ServicesIntroducing Amazon Connect Health: Agentic AI for healthcare, built for the people who deliver itAWS announced Amazon Connect Health, a new agentic AI solution for healthcare that automates high-volume administrative tasks such as appointment scheduling, clinical documentation, and medical coding, built to reduce burden on clinicians and staff. The solution, built on Amazon Connect, is now generally available with features including patient verification, appointment management, ambient documentation, and medical coding integrated with EHR systems. Customer testimonials from organizations including Amazon One Medical, Netsmart, Veradigm, Greenway Health, and Pelago report measurable outcomes including over a million ambient documentation visits, 275% adoption increase, and hundreds of clinician hours reclaimed monthly.BhbusinessRevisiting the Case for Tobacco Cessation Services in the Wake of the Opioid CrisisTobacco use remains the leading cause of preventable death in the U.S., yet addiction providers often under-treat it, focusing instead on opioid use disorder. Reimbursement gaps and a fee-for-service model hinder concurrent treatment, though Pelago reports a 4.5-to-1 ROI and over $6,000 in savings per member. Shifting to value-based care and equal reimbursement could expand tobacco cessation services.MedCity NewsLantern Teams Up with Pelago to Expand Access to Substance Use Disorder TreatmentLantern, a Dallas-based specialty care platform, has launched an exclusive partnership with Pelago, a New York City-based digital clinic for substance use management, enabling Lantern's employer and health plan clients to access Pelago's substance use disorder treatment services. The partnership addresses a need among 49 million U.S. adult workers battling substance use disorders, with Pelago offering care teams, medication-assisted treatment, and vetted inpatient facilities. Pelago aims to differentiate itself from competitors like Bicycle Health, Ophelia, and Boulder Care by focusing on serving employers rather than health plans including Medicaid.BhbusinessFast-growing SUD Provider Pelago Pegs New PresidentPelago has appointed Frank Jennings as its new president, replacing co-founder Dr. Sarim Siddiqui who stepped down from the role in September. Jennings joins from Castlight Health, where he served as chief sales officer for three years. The appointment comes shortly after Pelago raised $58 million in a Series C financing round and expanded its substance use disorder treatment platform to include teens.